AOD-9604
Metabolic · By Preptide Pro editorial team · Last updated
AOD-9604 is a metabolic peptide, and it is not FDA-approved. A modified fragment of the growth hormone C-terminus. Studied in human trials for obesity, which did not show meaningful weight loss.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 71300630 |
|---|---|
| CAS number | 221231-10-3 |
| Molecular formula | C78H123N23O23S2 |
| Molecular weight | 1815.1 g/mol |
| Other names | AOD 9604, AOD9604, AOD-9604, RefChem:113278, Tyr-somatostatin (177-191), Somatostatin (177-191), Tyr-, Somatostatin (177-191), tyrosyl-, UNII-7UP768IP4M |
Is AOD-9604 FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on AOD-9604?
PubMed lists 23 records for “AOD-9604 OR AOD9604”, of which 0 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. | Sports Med | 2026 Aug |
| Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices. | Analyst | 2026 Jul 27 |
| The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. | Front Endocrinol (Lausanne) | 2026 |
| Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. | J Am Acad Orthop Surg Glob Res Rev | 2026 Jan 1 |
| Human sports drug testing by mass spectrometry. | Mass Spectrom Rev | 2017 Jan |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.